Reimbursement Unraveled: Will New French Medtech Innovation Plans Hit The Spot?

Securing reimbursement for innovative medical devices in France calls for high levels of human and financial input. Yet the often cumbersome and misfiring adoption procedures deter manufacturers from approaching this ostensibly attractive medical device market – Europe’s second largest. But Corinne Lebourgeois of MedC. Partners explains that a revamped “forfait innovation” might provide the much-needed change.